Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial
Kadowaki T, Isendahl J, Khalid U, et al.
Lancet Diabetes Endocrinol. 2022;S2213-8587(22)00008-0.
Leggi